13:06 EST Pfizer (PFE) CEO sees launching 10 Phase 3 GLP-1 trials this year
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer CEO Bourla says looking to scale AI across business
- Pfizer’s New Colorectal Cancer Trial Puts PF-08634404 Head-to-Head With a Market Standard
- Pfizer’s Phase 3 C. Difficile Vaccine Study Targets a New Niche in the Adult Vaccine Market
- Pfizer Advances New Lung Cancer Combo in Global Phase 2/3 Trial: What Investors Should Watch
- Pfizer’s Abrocitinib Atopic Dermatitis Study Nears Data Milestone: What Investors Should Watch